Please use this identifier to cite or link to this item: https://hdl.handle.net/10356/162011
Title: Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection
Authors: Kali, Suresh Kumar
Dröge, Peter
Murugan, Priyatharshini
Keywords: Science::Biological sciences
Issue Date: 2021
Source: Kali, S. K., Dröge, P. & Murugan, P. (2021). Interferon β, an enhancer of the innate immune response against SARS-CoV-2 infection. Microbial Pathogenesis, 158, 105105-. https://dx.doi.org/10.1016/j.micpath.2021.105105
Journal: Microbial Pathogenesis
Abstract: COVID-19 exhibits a global health threat among the elderly and the population with underlying health conditions. During infection, the host's innate immune response acts as a frontline of defense by releasing cytokines such as type I interferon (IFN α and β) thereby initiating antiviral activity. However, this particular interferon response is interrupted by factors such as SARS-CoV-2 non-structural proteins, aging, diabetes, and germ-line errors eventually making the host more susceptible to illness. Therefore, enhancing the host's innate immune response by administering type I IFN could be an effective treatment against COVID-19. Here, we highlight the importance of innate immune response and the role of IFN β monotherapy against COVID-19.
URI: https://hdl.handle.net/10356/162011
ISSN: 0882-4010
DOI: 10.1016/j.micpath.2021.105105
Rights: © 2021 Elsevier Ltd. All rights reserved.
Fulltext Permission: none
Fulltext Availability: No Fulltext
Appears in Collections:SBS Journal Articles

SCOPUSTM   
Citations 50

3
Updated on Nov 21, 2022

Web of ScienceTM
Citations 50

3
Updated on Nov 21, 2022

Page view(s)

18
Updated on Nov 26, 2022

Google ScholarTM

Check

Altmetric


Plumx

Items in DR-NTU are protected by copyright, with all rights reserved, unless otherwise indicated.